The German government has awarded the 2015 Future prize, worth €250,000, to a respiratory medicine research team led by Ardeschir Ghofrani at the University of Gießen.
Ghofrani’s team won the prize for developing a drug to relieve the symptoms of two forms of pulmonary hypertension, according to a press release on 3 December from the Deutsche Forschungsgemeinschaft (DFG), Germany’s largest public research funder.
The team discovered a mechanism that can affect the molecular processes in cardiopulmonary circulation that may also be relevant to other diseases. The team was nominated for the prize by Acatech, a science and engineering academy.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.